BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21468584)

  • 1. Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts.
    Xu L; Qu X; Luo Y; Zhang Y; Liu J; Qu J; Zhang L; Liu Y
    Mol Med Rep; 2011; 4(3):407-11. PubMed ID: 21468584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts].
    Xu L; Qu XJ; Liu YP; Liu J; Zhang Y; Hou KZ; Jiang YH
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):484-8. PubMed ID: 22093622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts.
    Xu L; Qu X; Zhang Y; Hu X; Yang X; Hou K; Teng Y; Zhang J; Sada K; Liu Y
    FEBS Lett; 2009 Mar; 583(5):943-8. PubMed ID: 19223002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetuximab enhances TRAIL-induced gastric cancer cell apoptosis by promoting DISC formation in lipid rafts.
    Xu L; Hu X; Qu X; Hou K; Zheng H; Liu Y
    Biochem Biophys Res Commun; 2013 Sep; 439(2):285-90. PubMed ID: 23973713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells.
    Ouyang W; Yang C; Zhang S; Liu Y; Yang B; Zhang J; Zhou F; Zhou Y; Xie C
    Int J Oncol; 2013 Feb; 42(2):699-711. PubMed ID: 23258590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apple procyanidins activate apoptotic signaling pathway in human colon adenocarcinoma cells by a lipid-raft independent mechanism.
    Maldonado-Celis ME; Bousserouel S; Gossé F; Lobstein A; Raul F
    Biochem Biophys Res Commun; 2009 Oct; 388(2):372-6. PubMed ID: 19666002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redistribution of DR4 and DR5 in lipid rafts accounts for the sensitivity to TRAIL in NSCLC cells.
    Ouyang W; Yang C; Liu Y; Xiong J; Zhang J; Zhong Y; Zhang G; Zhou F; Zhou Y; Xie C
    Int J Oncol; 2011 Dec; 39(6):1577-86. PubMed ID: 21769428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
    Delmas D; Rébé C; Micheau O; Athias A; Gambert P; Grazide S; Laurent G; Latruffe N; Solary E
    Oncogene; 2004 Nov; 23(55):8979-86. PubMed ID: 15480430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-elemene increases the sensitivity of gastric cancer cells to TRAIL by promoting the formation of DISC in lipid rafts.
    Xu L; Guo T; Qu X; Hu X; Zhang Y; Che X; Song H; Gong J; Ma R; Li C; Fan Y; Ma Y; Hou K; Wu P; Dong H; Liu Y
    Cell Biol Int; 2018 Sep; 42(10):1377-1385. PubMed ID: 29957841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells.
    Yan S; Qu X; Xu L; Che X; Ma Y; Zhang L; Teng Y; Zou H; Liu Y
    Anticancer Drugs; 2014 Jul; 25(6):683-9. PubMed ID: 24710190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
    Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI
    Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
    Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN
    Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells.
    Xu L; Zhang Y; Liu J; Qu J; Hu X; Zhang F; Zheng H; Qu X; Liu Y
    Eur J Cancer; 2012 Nov; 48(17):3288-99. PubMed ID: 22456178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
    Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts.
    Psahoulia FH; Drosopoulos KG; Doubravska L; Andera L; Pintzas A
    Mol Cancer Ther; 2007 Sep; 6(9):2591-9. PubMed ID: 17876056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of TRAIL and its receptors in gastric cancer and the apoptotic effect of rh-TRAIL on SGC7901 cells.
    Hu JK; Yang K; Li CM; Zhang B; Chen ZX; Chen XZ; Chen JP
    Oncol Rep; 2009 Mar; 21(3):681-8. PubMed ID: 19212626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation.
    Kim YH; Lee YJ
    J Cell Biochem; 2007 Mar; 100(4):998-1009. PubMed ID: 17031854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TRAIL, DR4, and DR5 in bladder cancer: correlation with response to adjuvant therapy and implications of prognosis.
    Li Y; Jin X; Li J; Jin X; Yu J; Sun X; Chu Y; Xu C; Li X; Wang X; Kakehi Y; Wu X
    Urology; 2012 Apr; 79(4):968.e7-15. PubMed ID: 22244504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ
    Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.